Septic Shock With a Dubious Penicillin Allergy and a Prior ESBL
A 71-year-old woman (82 kg) is admitted with ascending cholangitis and septic shock. BP 84/48 mmHg on norepinephrine 0.15 mcg/kg/min, HR 122 bpm, lactate 4.2 mmol/L, urine output 0.3 mL/kg/h. Creatinine is 2.8 mg/dL (baseline 0.9) and she is not yet on renal replacement therapy. Six months ago she had an ESBL-producing E. coli urinary tract infection treated with ertapenem. The chart lists "penicillin allergy" from a childhood illness documented as a maculopapular rash without urticaria or angioedema. Piperacillin-tazobactam was started in the ED, and blood cultures were drawn. She has been in a hospital twice in the past year.
1. How do you interpret the penicillin allergy label, and what empiric regimen do you recommend pending cultures? Give doses and rationale.
Read the worked answer
The label is not a true allergy. A childhood maculopapular rash without urticaria, angioedema, bronchospasm, or hypotension is not IgE-mediated and does not preclude beta-lactam use. Even for anaphylaxis, carbapenem cross-reactivity with penicillin is <1%. Depriving a septic shock patient of a beta-lactam is the larger harm.
The bigger issue is the prior ESBL organism. Piperacillin-tazobactam is inadequate for a likely ESBL-producing Enterobacterales infection, and in this biliary source, prior ESBL isolation increases the risk substantially.
Recommend: meropenem 1 g IV every 8 hours, infused over 3 hours. If local resistance rates are high or the prior isolate had a meropenem MIC ≥2, use 2 g every 8 hours extended infusion. No need for a second gram-negative agent (aminoglycoside) if source control is achieved, and no need for aztreonam.
Add vancomycin 25–30 mg/kg actual body weight loading dose only if MRSA risk is present (recent hospitalization qualifies as a reasonable trigger); stop it at 48–72 hours if cultures are negative and she is improving.
Source control matters more than the drug: arrange urgent biliary drainage (ERCP).
2. How would you dose vancomycin in this setting, and what monitoring would you build into the plan?
Read the worked answer
Load first: 25–30 mg/kg actual body weight = ~2000–2500 mg IV once, regardless of renal function - loading is about volume of distribution, not clearance, and she is in shock with capillary leak.
Then dose for the AKI: maintenance 15 mg/kg q24h with a first level before the second dose, then adjust to AUC24 400–600 mg·h/L using Bayesian or two-level AUC estimation (trough-only targeting is a fallback, target 15–20 mg/L for trough but AUC is preferred).
Monitoring plan:
- Daily serum creatinine and urine output; if she starts CRRT, vancomycin requirements rise (roughly 1 g q12h or 15–20 mg/kg q24h depending on effluent rate) - re-dose at CRRT initiation.
- Watch for synergy of nephrotoxicity: vancomycin plus piperacillin-tazobactam is a recognized risk - with meropenem this concern is smaller.
- Monitor for infusion reaction (flushing/"red man" with rapid infusion) - infuse over 60–120 minutes.
- Once cultures identify the organism, de-escalate: if methicillin-susceptible S. aureus, switch to cefazolin; if no gram-positive pathogen, stop vancomycin.
Document the allergy clarification so future admissions do not repeat the cycle.
3. The intensivist asks whether to give 30 mL/kg of crystalloid up front. How do you decide, and what endpoints and alternatives do you propose?
Read the worked answer
30 mL/kg is a starting suggestion, not a mandate. In this patient it would mean ~2.5 L, which risks pulmonary edema in a septic patient who may have occult cardiac dysfunction and who is already oliguric with an AKI - volume overload is harder to undo than under-resuscitation is to correct.
Do it in assessed boluses: 250–500 mL balanced crystalloid over 10–15 minutes, reassessing after each with dynamic measures:
- Passive leg raise or end-expiratory occlusion test.
- Pulse pressure variation if she is fully ventilated without arrhythmia.
- Focused echo: IVC, LV function, B-lines.
- Lactate clearance, capillary refill, urine output - not CVP alone.
Start norepinephrine early (she is already on it) to maintain MAP 65 mmHg rather than chasing pressure with volume alone.
If she needs more volume but lungs are getting wet, use albumin 5% 250 mL boluses as an alternative, and consider early ultrafiltration or CRRT if she becomes anuric and edematous - this also solves the vancomycin and acid-base issues.
Timing: source control within 6–12 hours; antibiotics within 1 hour of recognition. Reassess fluid responsiveness at least every hour and stop the moment it is negative.